Editorial Commentary
Durvalumab and olaparib with chemotherapy improve progression-free survival in first-line metastatic endometrial cancer: a new promising combination strategy?
Gynecology and Pelvic Medicine
2025;
8:
30
.
(30 September 2025)
Editorial Commentary
Prognostic analysis of single-agent olaparib or combination cediranib and olaparib for platinum sensitive recurrent ovarian cancer: overall survival outcomes from NRG-GY004
Gynecology and Pelvic Medicine
2025;
8:
29
.
(30 September 2025)
Editorial Commentary
A review: patient questions about use of vaginal ring pessaries for prolapse
Gynecology and Pelvic Medicine
2025;
8:
28
.
(30 September 2025)
Editorial Commentary
Improving survival in recurrent ovarian cancer, miles to go before we sleep
Gynecology and Pelvic Medicine
2025;
8:
27
.
(30 September 2025)
Case Report
Successful delivery in pregnancy complicated by multiple Takayasu arteritis: a case report and clinical experience
Gynecology and Pelvic Medicine
2025;
8:
26
.
(30 September 2025)
Review Article
Application progress of radiofrequency (RF) therapy in pelvic floor disorders (PFDs): a narrative review focusing on randomized controlled trials
Gynecology and Pelvic Medicine
2025;
8:
25
.
(30 September 2025)
Review Article
Minimally invasive surgery in gynecologic oncology: a narrative review of controversies and clinical implications
Gynecology and Pelvic Medicine
2025;
8:
24
.
(30 September 2025)
Review Article
Feasibility of pelvic organ prolapse surgery using polytetrafluoroethylene mesh ORIHIME®—a narrative review of the recent articles
Gynecology and Pelvic Medicine
2025;
8:
23
.
(30 September 2025)
Surgical Technique
Laparoendoscopic single site surgery for cervical myomectomy: surgical technique
Gynecology and Pelvic Medicine
2025;
8:
22
.
(30 September 2025)
Original Article
Association of SNHG17/CDKN2B-AS1 polymorphisms with salpingitis and fallopian tube carcinoma susceptibility in the Chinese Han population
Gynecology and Pelvic Medicine
2025;
8:
21
.
(30 September 2025)